---
title: Novavax Covid-19 Vaccine Performs Well In Clinical Trials, But Variants Remain
  A Threat
date: "2021-03-16 18:04:03"
author: Forbes - Innovation
authorlink: https://www.forbes.com/sites/williamhaseltine/2021/03/16/novavax-covid-19-vaccine-performs-well-in-clinical-trials-but-variants-remain-a-threat/
tags:
- Forbes-Innovation
---
The new candidate uses a mechanism to prompt immune responses that is different from vaccines already in circulation, but remains effective against non-variant forms of the virus.